Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (1,490)

Search Parameters:
Keywords = topical infection

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
19 pages, 2144 KB  
Article
Nanoparticles Loaded with Lippia graveolens Essential Oil as a Topical Delivery System: In Vitro Antiherpetic Activity and Biophysical Parameters Evaluation
by Nancy Nallely Espinosa-Carranza, Rocío Álvarez-Román, David A. Silva-Mares, Luis A. Pérez-López, Catalina Leos-Rivas, Catalina Rivas-Morales, Juan Gabriel Báez-González and Sergio Arturo Galindo-Rodríguez
Pharmaceutics 2025, 17(10), 1286; https://doi.org/10.3390/pharmaceutics17101286 - 2 Oct 2025
Abstract
Background/Objectives: The skin is a protective barrier against pathogens such as herpes simplex virus type 1 (HSV-1), which causes recurrent and highly prevalent skin infections worldwide. The increasing resistance of HSV-1 to conventional treatments has driven the search for new therapeutic alternatives. [...] Read more.
Background/Objectives: The skin is a protective barrier against pathogens such as herpes simplex virus type 1 (HSV-1), which causes recurrent and highly prevalent skin infections worldwide. The increasing resistance of HSV-1 to conventional treatments has driven the search for new therapeutic alternatives. In this context, the essential oil of Lippia graveolens (EOL) has demonstrated promising antiviral activity; however, its high volatility limits direct skin application. To overcome this, polymeric nanoparticles (NPs) loaded with EOL were developed to improve its availability and antiviral efficacy. Methods: Nanoformulations were prepared by nanoprecipitation, and their antiviral activity against HSV-1 was evaluated using the plaque reduction assay. The effect of the nanoformulations on skin barrier integrity was assessed using an ex vivo porcine skin model and non-invasive techniques. Results: The NP-EOL exhibited physicochemical properties favorable for skin deposition, including a particle size around 200 nm, a polydispersity index of ≤ 0.2, and negative zeta potential. Moreover, NP-EOL showed 1.85-fold higher antiviral activity against HSV-1 compared with free EOL, while also reducing cytotoxicity in Vero cells. Conclusions: Results demonstrated that the NPs promoted skin hydration without altering pH or transepidermal water loss, suggesting they do not disrupt skin homeostasis. This study supports the potential of NP-based systems as effective topical delivery vehicles for EOL, representing a promising therapeutic alternative against HSV-1 skin infections. Full article
(This article belongs to the Special Issue Novel Drug Delivery Systems for the Treatment of Skin Disorders)
Show Figures

Graphical abstract

22 pages, 2609 KB  
Review
A Review of Coronaviruses in Wild Birds and Opportunities for Future Research on Migratory Waterfowl
by Allison A. Vestal-Laborde, Rebecca C. Christofferson, Kevin M. Ringelman and Ashley M. Long
Birds 2025, 6(4), 52; https://doi.org/10.3390/birds6040052 - 1 Oct 2025
Abstract
Coronaviruses (CoVs) were first described in poultry in the early 1930s and formally recognized as pathogens of both animal and human populations in the late 1960s. They are now considered among the most abundant viral families in the world. Though their distribution and [...] Read more.
Coronaviruses (CoVs) were first described in poultry in the early 1930s and formally recognized as pathogens of both animal and human populations in the late 1960s. They are now considered among the most abundant viral families in the world. Though their distribution and diversity remain understudied in wild animals, representatives from 13 orders of wild birds worldwide have tested positive for CoVs of the gamma and delta genera over the last 25 years. Many of these wild bird species are in the orders Charadriiformes (shorebirds and their relatives) and Anseriformes (waterfowl including ducks, geese, and swans). Waterfowl are particularly concerning as potential reservoirs for CoVs because they are globally distributed; often congregate in large, mixed-species flocks; and may exist in close proximity to humans and domesticated animals. This review describes the history and current knowledge of CoVs in birds, provides an updated list of global detections of CoVs in 124 species of wild birds as reported in the peer-reviewed literature since 2000, and highlights topics for future research that would help elucidate the role of waterfowl in CoV transmission. Our review reiterates the need for continuous surveillance to detect and monitor CoVs across all bird species and for standardization in data reporting and analysis of both negative and positive results. Such information is critical to understand the potential role of free-ranging birds in the maintenance, evolution, and transmission of the virus. Further, we believe that research on the potential impacts of coronavirus infections and coinfections on avian demographics, especially reproduction in waterfowl, is warranted given known consequences in domestic poultry. Full article
Show Figures

Figure 1

18 pages, 2035 KB  
Review
Streptomyces as Biofactories: A Bibliometric Analysis of Antibiotic Production Against Staphylococcus aureus
by Pablício Pereira Cardoso, Kamila Brielle Pantoja Vasconcelos, Sámia Rocha Pereira, Rafael Silva Cardoso, Ramillys Carvalho de Souza, Lucas Francisco da Silva Nogueira, Suelen Fabrícia dos Santos Bentes, Vivaldo Gemaque de Almeida and Silvia Katrine Rabelo da Silva
Antibiotics 2025, 14(10), 983; https://doi.org/10.3390/antibiotics14100983 - 30 Sep 2025
Abstract
Infections caused by Staphylococcus aureus pose significant public health challenges, particularly due to antibiotic-resistant strains like MRSA. In this context, Streptomyces, a genus known for producing natural antibiotics, emerges as a promising source for novel therapeutic agents. In this study, a bibliometric [...] Read more.
Infections caused by Staphylococcus aureus pose significant public health challenges, particularly due to antibiotic-resistant strains like MRSA. In this context, Streptomyces, a genus known for producing natural antibiotics, emerges as a promising source for novel therapeutic agents. In this study, a bibliometric analysis of the scientific literature (2015–2024) on Streptomyces as antibiotic biofactories against S. aureus was performed, aiming to identify publication trends, collaborative networks, and emerging research areas. Using the Web of Science database, searches were performed with descriptors (“Streptomyces” AND “Staphylococcus aureus”), including original articles and reviews in English. Data were analyzed with VOSviewer and Biblioshiny to visualize collaborative networks, keyword co-occurrences, and trends. A total of 755 articles from 3705 authors were analyzed, highlighting significant collaboration (98.7%). Publications showed marked growth, particularly in Microbiology (21.7%), Pharmacology and Pharmacy (16.8%), and Biotechnology and Applied Microbiology (16.1%). China and India led in publication volume, whereas the United States exhibited the highest citation impact. Key emerging research topics include biosynthesis and metabolic optimization, antimicrobial activity and bioprospecting, mechanisms of antibiotic action and bacterial resistance, and genomic analyses. Research on Streptomyces for antibiotic production against S. aureus demonstrates continuous expansion and global interest, emphasizing the importance of international collaboration and multidisciplinary approaches. Future studies should intensify exploration of biodiverse environments, genetic engineering applications, and combinatorial strategies to effectively address antimicrobial resistance. Full article
Show Figures

Figure 1

14 pages, 1194 KB  
Review
BCG Immunotherapy in Equine Sarcoid Treatment: Mechanisms, Clinical Efficacy, and Challenges in Veterinary Oncology
by Mariana Martins Monteiro, Elcidimar Lucas Aleixo de Castro, Ana Júlia Moaraes Pereira, Roberto Thiesen, Roberta Martins Crivelaro Thiesen and Felipe Masiero Salvarani
Viruses 2025, 17(10), 1322; https://doi.org/10.3390/v17101322 - 29 Sep 2025
Abstract
Equine sarcoids are the most common dermatological neoplasm in horses worldwide, associated with bovine papillomavirus (BPV) infection and characterized by high recurrence rates after conventional therapies. Bacillus Calmette–Guérin (BCG) immunotherapy has historically been used for sarcoid treatment, yet its role in contemporary veterinary [...] Read more.
Equine sarcoids are the most common dermatological neoplasm in horses worldwide, associated with bovine papillomavirus (BPV) infection and characterized by high recurrence rates after conventional therapies. Bacillus Calmette–Guérin (BCG) immunotherapy has historically been used for sarcoid treatment, yet its role in contemporary veterinary oncology remains debated. This narrative review critically examines the immunological mechanisms, clinical efficacy, and limitations of BCG in equine sarcoid therapy, while integrating insights from comparative oncology and One Health perspectives. A systematic search following PRISMA-based criteria identified 55 relevant studies published over the past four decades. Evidence indicates that BCG activates innate and adaptive immunity through TLR2/4 signaling, macrophage polarization, and enhanced CD8+ T-cell responses, leading to partial or complete sarcoid regression in select cases. However, therapeutic outcomes are highly variable due to heterogeneity in protocols (dose, strain, adjuvant use) and frequent adverse inflammatory reactions. Comparative analyses highlight that modern alternatives—such as cryotherapy, cisplatin-based protocols, and topical imiquimod—achieve higher efficacy and lower recurrence rates in many clinical settings. Although BCG is now rarely considered a first-line therapy, it remains relevant in resource-limited regions, such as the Amazon Biome, where cost-effectiveness and accessibility are critical. Future directions include randomized controlled trials, standardized protocols, and innovative approaches such as checkpoint inhibition, CRISPR-Cas9 targeting of viral oncogenes, and nanoparticle delivery systems. This review provides a balanced and data-driven synthesis of BCG immunotherapy, clarifying its historical contributions, current limitations, and translational opportunities for advancing equine and comparative oncology. Full article
(This article belongs to the Special Issue Viral Diseases of Domestic Animals)
12 pages, 1818 KB  
Case Report
Management of Severe Pediatric Lower Lip Defect After Canine Bite with Polyhexamethylene Biguanide (PHMB), Full-Thickness Skin Graft (FTSG) and Compression Foam: A Case Report
by Aba Lőrincz, Hermann Nudelman, Anna Gabriella Lamberti, Attila Vástyán, Enikő Molnár, Gábor Pavlovics and Gergő Józsa
Children 2025, 12(10), 1308; https://doi.org/10.3390/children12101308 - 28 Sep 2025
Abstract
Introduction: Pediatric lower-lip dog bite injuries are challenging due to contamination, tissue loss, and the need to maintain function, appearance, and psychological well-being. This single case describes immediate definitive closure using sharp debridement with adjunct polyhexanide (PHMB), a full-thickness skin graft (FTSG), [...] Read more.
Introduction: Pediatric lower-lip dog bite injuries are challenging due to contamination, tissue loss, and the need to maintain function, appearance, and psychological well-being. This single case describes immediate definitive closure using sharp debridement with adjunct polyhexanide (PHMB), a full-thickness skin graft (FTSG), and a polyurethane (PU) compression foam bolster. Methods: A 10-year-old boy with a severe contaminated lower-lip defect underwent debridement and 0.04% PHMB irrigation. An upper-arm FTSG was inset and compressed with a suture-anchored PU dressing. Topical PHMB gel was used perioperatively and for seven days after bolster removal. Oral antibiotics were given for five days. The patient was discharged eight days after the injury with detailed wound care instructions. Results: Immediate definitive closure was achieved with complete graft survival and no infection, necrosis, unplanned early dressing changes, or reoperations. At 12 months, oral competence, speech, lip mobility, and contour were preserved. However, mild residual esthetic differences remained (dyschromia, shallow border indentation, vellus hairs on the graft). Conclusion: In this single descriptive case, primary closure of a lower-lip injury with the combined intervention was associated with an uncomplicated functional course and manageable esthetic trade-offs at 12 months. These observations are descriptive; comparative studies with standardized functional, esthetic, and psychosocial measures are needed. Full article
(This article belongs to the Section Pediatric Orthopedics & Sports Medicine)
Show Figures

Figure 1

18 pages, 616 KB  
Systematic Review
Symptomatology of Long COVID Associated with Inherited and Acquired Thrombophilic Conditions: A Systematic Review
by Amelia Mae Heath and Dan Li
Viruses 2025, 17(10), 1315; https://doi.org/10.3390/v17101315 - 28 Sep 2025
Abstract
Thrombophilic conditions, conditions where blood has a tendency to form thrombi due to abnormal coagulatory processes, can affect the trajectory of diseases such as Post-Acute Sequelae of SARS-CoV-2 Infection, better known as Long COVID (LC), by worsening symptoms and complicating outlooks. As a [...] Read more.
Thrombophilic conditions, conditions where blood has a tendency to form thrombi due to abnormal coagulatory processes, can affect the trajectory of diseases such as Post-Acute Sequelae of SARS-CoV-2 Infection, better known as Long COVID (LC), by worsening symptoms and complicating outlooks. As a comorbidity in pro-coagulatory diseases such as COVID-19 and LC, patients with thrombophilic conditions may experience worse symptoms than their peers, due to this elevated level of hypercoagulation. A 15-week literature review through the public PubMed database was conducted to investigate the severity, mechanisms, and symptom profiles of thrombophilic patients with LC. Papers were only included if samples included participants with pre-existing tendencies for hypercoagulable states, and confirmation of SARS-CoV-2 infection via a Polymerase Chain Reaction test. Each paper included in this review was analyzed by topic and assessed for eligibility against the Joanna Briggs Institute’s Critical Appraisal tool. Each paper was also assessed for biases. Results from the 6 papers included in this review showed that LC could be predicted following COVID-19 illness by a hypercoagulable blood profile, indicating that LC may be linked to chronic hypercoagulation and inflammation post-infection. Additionally, symptoms linked to microthrombi formation, such as hair loss, arrhythmia, and dizziness, were exhibited more frequently in patients with thrombophilia and/or thrombophilic conditions, indicating that those with thrombophilic conditions may exhibit unique LC symptom profiles compared to healthy controls. This paper’s research is preliminary and thus is limited in the strength of its findings; However, further research into LC and its interactions with co-morbidities like thrombophilic conditions would aid in the development of better treatment plans for patients, such as the usage of anticoagulants or screening for hypercoagulable blood profiles post-COVID-19 to assess patient risk. Full article
(This article belongs to the Special Issue SARS-CoV-2, COVID-19 Pathologies, Long COVID, and Anti-COVID Vaccines)
Show Figures

Figure 1

17 pages, 1923 KB  
Article
Dermatophyte-Selective Imidazole-Thiosemicarbazides: Potent In Vitro Activity Against Trichophyton and Microsporum with No Anti-Candida Effect
by Agata Paneth, Katarzyna Dzitko, Adrian Bekier, Nazar Trotsko, Katarzyna Suśniak, Anita Ciesielska and Piotr Paneth
Int. J. Mol. Sci. 2025, 26(19), 9437; https://doi.org/10.3390/ijms26199437 - 26 Sep 2025
Abstract
Dermatophytes are highly infectious pathogenic fungi that colonize keratinized tissues like skin, hair, and nails, causing superficial infections such as tinea capitis, onychomycosis, tinea corporis, and tinea pedis in humans and animals. In immunocompromised patients, they may invade deeper tissues and organs, leading [...] Read more.
Dermatophytes are highly infectious pathogenic fungi that colonize keratinized tissues like skin, hair, and nails, causing superficial infections such as tinea capitis, onychomycosis, tinea corporis, and tinea pedis in humans and animals. In immunocompromised patients, they may invade deeper tissues and organs, leading to severe or life-threatening conditions if untreated or inadequately managed. While most infections respond to topical antifungals, some require complex treatment and show resistance to standard therapies. Therefore, novel antifungal agents are needed. We investigated the antidermatophytic activity of imidazole-thiosemicarbazides against Microsporum canis, Trichophyton spp., and Chrysosporium spp. using the broth microdilution method, comparing results to ketoconazole and amphotericin B through minimal inhibitory concentration (MIC), half-maximal inhibitory concentration (IC50), and selectivity index (SI). Iodine- and bromine-substituted compounds showed the strongest activity, with MICs of 15.15 (IC50 < 1 μM; SI > 213) and 73.46 μg/mL (IC50 < 1 μM; SI > 846) against T. tonsurans, and 3.87 (IC50 = 7.21 μM; SI > 29.6) and 7.38 μg/mL (IC50 = 11.06 μM; SI = 76.6) against M. canis. In silico analysis revealed interactions with α-keratin and lanosterol-14-α demethylase (the azole target enzyme), suggesting enhanced drug retention and action. These findings support these compounds as promising leads for further antifungal development. Full article
(This article belongs to the Section Molecular Microbiology)
Show Figures

Figure 1

18 pages, 392 KB  
Article
Effects of Intragastric Helicobacter pylori Distribution on Clinical Presentation, Upper Gastrointestinal Endoscopy, Esophageal Manometry, and pH–Impedance Metrics
by Ayça Eroğlu Haktanır and Altay Çelebi
J. Clin. Med. 2025, 14(19), 6818; https://doi.org/10.3390/jcm14196818 - 26 Sep 2025
Abstract
Background: The relationship between Helicobacter pylori (H. pylori) infection and gastroesophageal reflux disease (GERD) remains a topic of ongoing debate. In particular, the intragastric distribution of H. pylori—whether localized in the antrum or corpus—may influence gastric acid secretion and esophageal [...] Read more.
Background: The relationship between Helicobacter pylori (H. pylori) infection and gastroesophageal reflux disease (GERD) remains a topic of ongoing debate. In particular, the intragastric distribution of H. pylori—whether localized in the antrum or corpus—may influence gastric acid secretion and esophageal physiology in different ways. However, its potential effects on esophageal motility and reflux parameters have not been comprehensively evaluated using combined diagnostic tools. This study aimed to assess whether H. pylori positivity, based on its histologically confirmed intragastric localization, is associated with alterations in endoscopic, manometric, and reflux monitoring findings in patients with typical GERD symptoms. Methods: This retrospective study included 213 patients with typical reflux symptoms who underwent upper gastrointestinal endoscopy with gastric biopsies, high-resolution esophageal manometry (HREM), and 24 h multichannel intraluminal impedance–pH (MII-pH) monitoring. Based on histopathology, patients were classified into three groups: H. pylori-negative, antrum-predominant infection, and corpus-predominant infection. Clinical symptoms, endoscopic findings, reflux characteristics, and esophageal motility parameters were compared. Results: Of 213 patients, 90 were H. pylori-positive (60 antrum-predominant, 30 corpus-predominant). There were no significant differences between groups in terms of typical GERD symptoms, endoscopic esophagitis, DeMeester scores, acid exposure time, or mean nocturnal baseline impedance (MNBI). Nausea and chronic laryngitis were significantly more frequent in antral H. pylori-positive patients. Notably, contraction front velocity (CFV) was significantly lower in patients with antral H. pylori compared with H. pylori-negative individuals (p = 0.002), indicating subtle slowing of esophageal peristalsis. Although this reduction in CFV did not correlate with symptom severity or bolus clearance, it may represent early functional impairment of esophageal motility. Conclusions: Although H. pylori infection—particularly when antrum-predominant—is not associated with increased reflux burden or esophagitis, it may contribute to extra-esophageal symptoms and minor motility alterations such as reduced CFV. These findings suggest that routine H. pylori eradication in GERD patients may not be necessary solely based on reflux parameters. However, treatment decisions should be individualized based on symptom profiles and endoscopic findings, including the presence of peptic ulcers, premalignant gastric lesions, or a family history of gastric malignancy, in accordance with general H. pylori eradication criteria. Full article
Show Figures

Figure 1

21 pages, 293 KB  
Review
Orbital Complications of Chronic Rhinosinusitis: A Contemporary Narrative Review of the Ophthalmologic Impact and Therapeutic Role of Functional Endoscopic Sinus Surgery
by Zacharias Kalentakis, Nikolaos Garifallos, Georgia Baxevani, Kyriaki Panagiotou, Evangelos Spanos, Ioannis Vlastos and Alexandre Karkas
Sinusitis 2025, 9(2), 18; https://doi.org/10.3390/sinusitis9020018 - 24 Sep 2025
Viewed by 116
Abstract
Chronic rhinosinusitis (CRS) is a prevalent inflammatory condition of the paranasal sinuses. While the burden of CRS on quality of life and respiratory health is well recognized, its potential impact on orbital structures is an area of growing clinical attention. The orbit is [...] Read more.
Chronic rhinosinusitis (CRS) is a prevalent inflammatory condition of the paranasal sinuses. While the burden of CRS on quality of life and respiratory health is well recognized, its potential impact on orbital structures is an area of growing clinical attention. The orbit is separated from the ethmoid and frontal sinuses by only thin bony laminae. Chronic sinus disease can therefore easily extend beyond the sinuses to involve the orbit, leading to ophthalmologic complications that range from eyelid edema changes to severe, sight-threatening emergencies. Traditionally, orbital complications are more commonly associated with acute sinusitis (particularly in children), but contemporary evidence highlights that chronic rhinosinusitis and its sequelae—including mucoceles, chronic infections (bacterial or fungal), and protracted inflammation—can likewise produce significant orbital consequences. This narrative review synthesizes the current literature on the orbital complications of chronic rhinosinusitis, highlighting clinical, relevant anatomical/pathophysiological pathways, preoperative versus postoperative findings, and the therapeutic impact of FESS. Through this review, clinicians in both otolaryngology and ophthalmology can gain an updated understanding of this interdisciplinary topic, guiding prompt recognition and effective management of CRS patients with orbital involvement. Full article
22 pages, 7468 KB  
Article
Laponite®-Based Smart Hydrogels for Sustained Topical Delivery of Silver Sulfadiazine: A Strategy for the Treatment of Contaminated or Biofilm-Forming Wounds
by Jonas Lira do Nascimento, Michely Conceição Viana da Costa, Leticia Farias de Macêdo, Luiz Henrique Chaves de Macêdo, Ricardo Olímpio de Moura, Tomás Jeferson Alves de Mélo, Wilma Raianny Vieira da Rocha, Ana Cristina Figueiredo de Melo Costa, José Lamartine Soares-Sobrinho and Dayanne Tomaz Casimiro da Silva
Pharmaceutics 2025, 17(9), 1234; https://doi.org/10.3390/pharmaceutics17091234 - 22 Sep 2025
Viewed by 324
Abstract
Background/Objectives: Silver sulfadiazine (AgSD) is widely used in the topical treatment of burns and infected wounds, but its conventional formulations present drawbacks such as poor water solubility, the need for multiple daily applications, and patient discomfort. To overcome these limitations, this study [...] Read more.
Background/Objectives: Silver sulfadiazine (AgSD) is widely used in the topical treatment of burns and infected wounds, but its conventional formulations present drawbacks such as poor water solubility, the need for multiple daily applications, and patient discomfort. To overcome these limitations, this study aimed to develop and evaluate Laponite® (LAP)-based hydrogels loaded with AgSD for controlled release and enhanced antimicrobial and antibiofilm efficacy, offering a promising alternative for the treatment of contaminated or biofilm-forming wounds. Methods: Laponite®-based hydrogels containing 1% and 1.2% AgSD (LAP@AgSD) were prepared using a one-pot method. The formulations were characterized rheologically, thermally, and structurally. In vitro drug release was assessed using Franz diffusion cells, and mathematical modeling was applied to determine release kinetics. Antibacterial and antibiofilm activities were evaluated against Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa using standardized microbiological methods. Results: LAP@AgSD hydrogels exhibited pseudoplastic behavior, high structural integrity, and enhanced thermal stability. In vitro release assays revealed a sustained release profile, best fitted by the Weibull model, indicating diffusion-controlled mechanisms. Antibacterial assays demonstrated concentration-dependent activity, with LAP@AgSD 1.2% showing superior efficacy over LAP@AgSD 1% and comparable performance to the commercial silver sulfadiazine cream (CC-AgSD). Biofilm inhibition was significant for all formulations, with CC-AgSD 1% exhibiting the highest immediate activity, while LAP@AgSD 1.2% provided sustained antibiofilm potential. Conclusions: LAP-based hydrogels are promising smart delivery systems for AgSD, combining mechanical robustness, controlled drug release, and effective antibacterial and antibiofilm activities. These findings support their potential use in topical therapies for infected and chronic wounds, particularly where biofilm formation is a challenge. Full article
(This article belongs to the Special Issue Hydrogels-Based Drug Delivery System for Wound Healing)
Show Figures

Graphical abstract

12 pages, 1601 KB  
Article
Antimicrobial Resistance of Clostridioides (Clostridium) difficile in Cambodia
by Lengsea Eng, Papanin Putsathit, Su-Chen Lim, Jessica M. Chisholm, Deirdre A. Collins, Archie C. A. Clements, Kefyalew Addis Alene and Thomas V. Riley
Antibiotics 2025, 14(9), 950; https://doi.org/10.3390/antibiotics14090950 - 19 Sep 2025
Viewed by 281
Abstract
Background/Objectives: Antimicrobial resistance (AMR) remains a major topic of interest in infectious disease management. We studied AMR in Clostridioides difficile isolated in Cambodia. Methods: Agar dilution susceptibility testing was performed according to the CLSI guidelines to determine minimal inhibitory concentrations (MICs) of 10 [...] Read more.
Background/Objectives: Antimicrobial resistance (AMR) remains a major topic of interest in infectious disease management. We studied AMR in Clostridioides difficile isolated in Cambodia. Methods: Agar dilution susceptibility testing was performed according to the CLSI guidelines to determine minimal inhibitory concentrations (MICs) of 10 antimicrobials for 192 isolates of C. difficile from four populations in Cambodia: hospitalised adults, hospitalised children, children from an outpatient department (OPD), and healthy adolescents in the community. Results: Using the CLSI MIC breakpoints for anaerobes and EUCAST breakpoints for C. difficile, all isolates were susceptible to vancomycin, metronidazole, fidaxomicin, and amoxicillin/clavulanic acid, and none were resistant to meropenem. The resistance proportions were for clindamycin, 88% (169/192); tetracycline, 50% (96/192); moxifloxacin, 20% (38/192); and rifaximin, 8% (15/192). Among the 169 clindamycin-resistant isolates, 56.8% (96/169) had an erythromycin MIC of >512 mg/L. Multidrug resistance (MDR) occurred in 20% (39/192) of the isolates, of which 82% (32/39) were non-toxigenic strains. The proportion of MDR varied between collections of isolates from different populations: 28.6% (22/77) in hospitalised adults, 29.8% (14/47) in hospitalised children, 5% (3/59) in OPD children, and none (00/07) in healthy adolescents in the community. Conclusions: C. difficile isolates from Cambodia remained susceptible to antimicrobials used to treat C. difficile infection: vancomycin, metronidazole, and fidaxomicin; however, high proportions of resistance to clindamycin and tetracycline were observed. The high number of MDR strains of C. difficile is a threat to AMR management in Cambodia and a factor contributing to the persistent spread of C. difficile in both hospital and community settings. Full article
Show Figures

Figure 1

31 pages, 8942 KB  
Article
Formulation Studies on Microemulsion-Based Polymer Gels Loaded with Voriconazole for the Treatment of Skin Mycoses
by Michał Gackowski, Anna Froelich, Oliwia Kordyl, Jolanta Długaszewska, Dorota Kamińska, Raphaël Schneider and Tomasz Osmałek
Pharmaceutics 2025, 17(9), 1218; https://doi.org/10.3390/pharmaceutics17091218 - 18 Sep 2025
Viewed by 282
Abstract
Background: Skin mycoses affect approximately 10% of the global population, and the range of effective topical antifungal agents remains limited. Voriconazole (VRC) is a broad-spectrum triazole with proven efficacy against drug-resistant fungal infections. This study aimed to develop and optimize VRC-loaded microemulsion (ME) [...] Read more.
Background: Skin mycoses affect approximately 10% of the global population, and the range of effective topical antifungal agents remains limited. Voriconazole (VRC) is a broad-spectrum triazole with proven efficacy against drug-resistant fungal infections. This study aimed to develop and optimize VRC-loaded microemulsion (ME) polymer gels (Carbopol®-based) for cutaneous delivery. Selected formulations also contained menthol (2%) as a penetration enhancer and potential synergistic antifungal agent. Methods: A comprehensive screening was performed using pseudoternary phase diagrams to identify stable oil/surfactant/co-surfactant/water systems. Selected MEs were prepared with triacetin, Etocas™ 35, and Transcutol®, then gelled with Carbopol®. Formulations were characterized for pH, droplet size, polydispersity index (PDI), and viscosity. In vitro VRC release was assessed using diffusion cells, while ex vivo permeation and skin deposition studies were conducted on full-thickness human skin. Rheological behavior (flow curves, yield stress) and texture (spreadability) were evaluated. Antifungal activity was tested against standard strain of Candida albicans and clinical isolates including a fluconazole-resistant strain. Results: The optimized ME (pH ≈ 5.2; droplet size ≈ 2.8 nm) was clear and stable with both VRC and menthol. Gelation produced non-Newtonian, shear-thinning hydrogels with low thixotropy, favorable for topical application. In ex vivo studies, performed with human skin, both VRC-loaded gels deposited the drug in the epidermis and dermis, with no detectable amounts in the receptor phase after 24 h, indicating retention within the skin. Menthol increased VRC deposition. Antifungal testing showed that VRC-containing gels produced large inhibition zones against C. albicans, including the resistant isolate. The VRC–menthol gel exhibited significantly greater inhibition zones than the VRC-only gel, confirming synergistic activity. Conclusions: ME-based hydrogels effectively delivered VRC into the skin. Menthol enhanced drug deposition and demonstrated synergistic antifungal activity with voriconazole. Full article
(This article belongs to the Special Issue Dermal and Transdermal Drug Delivery Systems)
Show Figures

Graphical abstract

19 pages, 2806 KB  
Article
Mapping the Landscape of Marine Giant Virus Research: A Scientometric Perspective (1996–2024)
by Kang Eun Kim, Man Deok Seo, Sukchan Lee and Taek-Kyun Lee
J. Mar. Sci. Eng. 2025, 13(9), 1797; https://doi.org/10.3390/jmse13091797 - 17 Sep 2025
Viewed by 323
Abstract
Although giant viruses have introduced new perspectives on the definition and evolution of viruses and are increasingly recognized for their significant biological roles within marine ecosystems, systematic evaluations of development trends and scientific contributions in this research field remain limited. This study conducted [...] Read more.
Although giant viruses have introduced new perspectives on the definition and evolution of viruses and are increasingly recognized for their significant biological roles within marine ecosystems, systematic evaluations of development trends and scientific contributions in this research field remain limited. This study conducted a bibliometric analysis of the global academic literature on marine giant viruses (MGVs), focusing on nucleocytoplasmic large DNA viruses (NCLDVs), from 1996 to 2024. Using the Web of Science Core Collection, 1544 publications related to giant viruses were identified. After filtering using marine-related keywords and manual review, 300 studies specifically addressing marine giant viruses were selected for the final analysis. This study comprehensively examined the structural characteristics and evolutionary trends in this field by analyzing annual publication productivity, citation patterns, contributions by countries and institutions, author collaboration networks, and keyword co-occurrence patterns. The results show that research on MGVs has steadily increased since the mid-2000s, with a notable surge after 2018 driven by advancements in metagenomics, next-generation sequencing technologies, and global ocean exploration initiatives. The United States and France have taken leading positions in terms of research productivity and impact, with key institutions such as the CNRS (Centre National de la Recherche Scientifique) and Aix-Marseille Université playing central roles. A multipolar network of international collaborations between countries and institutions has been formed. Research topics have evolved from an early focus on virus classification and genome analysis to more diverse themes, including interactions with marine microbiota, viral ecological functions, infection dynamics, virophage research, and metagenome-based ecosystem-level studies. This study provides an overview of the chronological and structural evolution of the marine giant virus research field by systematically presenting key research themes and collaborative networks. The results provide a valuable foundation for determining future academic directions and planning strategic research initiatives. Furthermore, it is expected to facilitate interdisciplinary research in marine biology, environmental science, systems biology, and artificial intelligence-based functional predictions. Full article
(This article belongs to the Section Marine Biology)
Show Figures

Figure 1

9 pages, 259 KB  
Article
Clinical Characteristics, Outcomes, and Cost Associated with Inpatient Intensive Care for Infectious Keratitis
by Anne Strong Caldwell, Ari M. Stoner, Ellen Rhodes, Nihaal Mehta and Michael C. Chen
Medicina 2025, 61(9), 1680; https://doi.org/10.3390/medicina61091680 - 16 Sep 2025
Viewed by 230
Abstract
Background and Objectives: Infectious keratitis (IK) is typically managed in an outpatient setting, but patients with severe infections or significant social barriers may require hospital admission. In safety-net hospital systems, these admissions to the intensive care unit (ICU) occur due to hospital [...] Read more.
Background and Objectives: Infectious keratitis (IK) is typically managed in an outpatient setting, but patients with severe infections or significant social barriers may require hospital admission. In safety-net hospital systems, these admissions to the intensive care unit (ICU) occur due to hospital protocols for frequent topical antibiotic administration. This study aims to characterize the ocular and social risk factors, visual outcomes, and financial costs associated with ICU admission for IK in an underserved population. Materials and Methods: We conducted a retrospective case series of all patients admitted to the ICU for primary treatment of IK at the Denver Health Medical Center between 1 January 2017 and 31 December 2022. Patients admitted for other medical issues with concurrent IK were excluded. Demographic data, ocular and social risk factors, microbiological culture results, reasons for admission, length of stay, hospital charges, and clinical outcomes were obtained via chart review. Results: Fourteen patients with 16 ICU admissions were included. The average age was 51.7 years, and 79% were male. Most patients endorsed current illicit drug use (71%), and 36% were unhoused. The most common ocular risk factor was trauma (43%). Mean length of stay was 7.43 days, with a mean hospital charge of $48,535.90 per admission. Most ulcers were large (88%) and presented with poor vision (only 19% had better than hand motion vision). The most common reason for ICU admission was concern about outpatient compliance (63%). At last follow-up, 40% of patients had stable vision and 40% had improved vision compared to admission. Conclusions: ICU admission for IK in patients with significant social barriers may preserve vision, but it comes with substantial financial and societal cost. Alternative care strategies and preventative interventions should be considered to reduce reliance on ICU resources while maintaining effective treatment. Full article
(This article belongs to the Special Issue Underserved Ophthalmology Healthcare)
14 pages, 247 KB  
Article
Examining the Moderating Role of Formal Sex Education on Contraceptive Use Among Individuals with Sensory Disabilities
by Luis Enrique Espinoza, Amanda M. Hinson-Enslin, Heather F. de Vries McClintock, Paris G. Rangel and Alina M. Jordan
Disabilities 2025, 5(3), 82; https://doi.org/10.3390/disabilities5030082 - 16 Sep 2025
Viewed by 1008
Abstract
This study examined the association between formal sex education (FSE), sensory disability status, and contraceptive use among U.S. women. Women with disabilities face barriers to contraceptive decision-making, such as limited accessible FSE content and topics. Data were weighted and analyzed from the 2011–2019 [...] Read more.
This study examined the association between formal sex education (FSE), sensory disability status, and contraceptive use among U.S. women. Women with disabilities face barriers to contraceptive decision-making, such as limited accessible FSE content and topics. Data were weighted and analyzed from the 2011–2019 National Survey of Family Growth among women 15–25 years of age. Multivariable logistic regression and moderation analysis examined the association between sensory disability status, contraceptive use during last sexual encounter, and FSE topics. Women with hearing loss or both hearing loss and vision loss were less likely to use contraceptives during last sexual encounter than women without sensory disability (hearing loss: adjusted odds ratio (aOR): 0.36; 95% confidence interval (CI): 0.14, 0.96; both: aOR: 0.28; CI: 0.08, 0.91). Exploratory moderation analysis showed women with vision loss who received FSE on birth control methods (aOR: 6.14; 95% CI: 1.70, 22.23) and on sexually transmitted infections (aOR: 28.24; 95% CI: 1.71, 46.63). The estimates were based on small numbers of individuals within each subgroup and wide confidence intervals, and thus should be interpreted with caution. The findings point to differences in contraceptive use according to sensory disability status, indicating future studies need larger sample sizes to better understand the role of FSE for women with sensory disability. Full article
Back to TopTop